COMPOSITION AND METHOD FOR REDUCING FUNGAL INFECTIONS IN CROPS

Abstract

A composition useful for application to plants, seeds or soil to inhibit fungal infections comprises a protein source inoculated with from 510.sup.7 cfu to 510.sup.9 cfu of a Bacillus amyloliquefaciens strain per gram of the protein source.

Claims

1. A composition comprising: a protein source inoculated with from 510.sup.7 to 510.sup.9 cfu of a Bacillus amyloliquefaciens strain per gram of the protein source.

2. The composition of claim 1, wherein the Bacillus amyloliquefaciens strain has the identifying characteristics of a bacterium designated strain OBT 712, deposited as ATCC Accession No. PTA-122189.

3. The composition of claim 1, wherein the Bacillus amyloliquefaciens strain has the identifying characteristics of a bacterium designated strain OBT 730, deposited as ATCC Accession No. PTA-124660.

4. The composition of claim 1, wherein the protein source is soybean flour.

5. The composition of claim 1, wherein the protein source is cotton seed meal.

6. A composition comprising: effluent from a Bacillus amyloliquefaciens strain grown in a cultivation medium.

7. The composition of claim 6, wherein the Bacillus amyloliquefaciens strain has the identifying characteristics of a bacterium designated strain OBT 712, deposited as ATCC Accession No. PTA-122189.

8. The composition of claim 6, wherein the Bacillus amyloliquefaciens strain has the identifying characteristics of a bacterium designated strain OBT 730, deposited as ATCC Accession No. PTA-124660.

9. The composition of claim 6, wherein the cultivation medium is tryptic soy broth.

10. A process for inhibiting fungal infections in a plant, comprising: applying to a seed from which the plant grows, or to a place where the plant is grown, a composition including a protein source inoculated with from 510.sup.7 cfu to 510.sup.9 cfu of a Bacillus amyloliquefaciens strain per gram of the protein source.

11. The process of claim 10, wherein the composition is added to the soil in which the plant is grown, such that the composition is present in the soil at an amount of from about 0.33% to about 5% of the mass of the soil.

12. The process of claim 10, wherein the Bacillus amyloliquefaciens strain has the identifying characteristics of a bacterium designated strain OBT 712, deposited as ATCC Accession No. PTA-122189.

13. The process of claim 10, wherein the Bacillus amyloliquefaciens strain has the identifying characteristics of a bacterium designated strain OBT 730. deposited as ATCC Accession No. PTA-124660.

14. The process of claim 10, wherein the protein source is soybean flour.

15. The process of claim 10, wherein the protein source is cotton seed meal.

16. The process of claim 10, wherein the plant is infected with a strain of Fusarium oxysporum.

17. A process for inhibiting fungal infections in a plant, comprising: applying to the plant, or to a place where the plant is grown, effluent from a Bacillus amyloliquefaciens strain grown in a cultivation medium.

18. The process of claim 17, wherein the Bacillus amyloliquefaciens strain has the identifying characteristics of a bacterium designated strain OBT 712, deposited as ATCC Accession No. PTA-122189,

19. The process of claim 17, wherein the Bacillus amyloliquefaciens strain has the identifying characteristics of a bacterium designated strain OBT 730, deposited as ATCC Accession No. PTA-124660.

20. The process of claim 17, wherein the cultivation medium is tryptic soy broth.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0006] FIG. 1 is a bar chart showing the inhibitory effect of fermentation medium effluent from different bacteria strains on Fusarium oxysporum conidia germination.

[0007] FIG. 2 is a bar chart showing the inhibitory effect of fermentation medium effluent from different bacteria strains on Fusarium oxysporum conidia numbers.

[0008] FIG. 3 is a bar chart showing the inhibitory effect of adding a composition containing a protein source inoculated with a strain of Bacillus amyloliquefaciens to a soil in which a plant is grown.

[0009] FIG. 4 is a bar chart showing that the addition of the Bacillus amyloliquefaciens strain alone, without the protein source, to soil in which a plant is grown does not effectively inhibit Fusarium oxysporum.

[0010] FIG. 5 is a bar chart showing that soybean flour inoculated with a strain of Bacillus amyloliquefaciens is much more effective than soybean flour alone at inhibiting Fusarium oxysporum in soil.

DETAILED DESCRIPTION OF THE DISCLOSED EMBODIMENTS

[0011] Based on experiments in which various Bacillus species were screened for their ability to promote growth of basil plants treated with a protein source selected from cotton seed meal, soybean flour and hydrolyzed feather meal, it was determined that the growth response to cotton seed meal and soybean flour was very poor regardless of the species of Bacillus and amount of Bacillus used. It was also determined that the growth response to hydrolyzed feather meal was good regardless of the amount or species of Bacillus used. This suggested to the inventors that the soybean flour and cotton seed meal was being consumed by bacteria and incorporated in the mass of the bacteria. The bacteria responsible for metabolizing the protein sources could be native bacteria, added bacteria (the protein source inoculant), or a combination of both inoculant and native bacteria. This suggested to the inventors that certain protein sources, such as soybean flour and cotton seed meal, could be used to supplement the growth of a biocontrol organism, such as a fungicidial bacteria.

[0012] Based on separate experiments in which various Bacillus strains were screened for their ability to inhibit germination of conidia in water and their ability to lyse conidia in water, it was determined that the effluent from tryptic soy broth (TSB) media used for cultivating the various Bacillus strains tested typically contained secreted substances capable of inhibiting germination of conidia from Fusarium oxysporum. However, as shown in FIG. 1, there were exceptions, such as B. pumilus strain BP, which did not appreciably inhibit Fusarium oxysporum. Also, as shown in FIG. 1, B. amyloliquefaciens strains OBT 730 (deposited as ATCC Accession No. PTA-124660), and OBT 712 (deposited as ATCC Accession No. PTA-122189) were particularly effective at inhibiting Fusarium conidia germination.

[0013] FIG. 2 shows that the ability of effluents from strains OBT 730 and OBT 712 to lyse Fusarium oxysporum conidia were particularly good, with over 70% of the conidia disappearing. Among the remaining conidia, percent germination was much lower for the effluents from strains OBT 730 and OBT 712 than observed when conidia were treated with effluent from other cultures.

[0014] Strain OBT 712 is a stock strain sold in most Bacillus-based products sold by Osprey Biotechnics, Sarasota, Fla., and strain OBT 730 was isolated by Osprey Biotechnics from a soil sample.

[0015] Strain OBT 712 was selected for further analysis. Specifically, experiments were conducted to determine the ability of strain OBT 712 to reduce Fusarium conidia concentrations in soil, both with and without soybean flour. Soybean flour was inoculated with 510.sup.8 cfu B. amyloliquefaciens strain OBT 712 per gram of soybean flour. The inoculated soybean flour was added to soil in amounts of zero, 0.33%, 1% and 5%, and Fusarium oxysporum conidia was added at 510.sup.5 conidia per gram of soil. The addition of B. amyloliquefaciens-inoculated soybean flour very substantially reduced Fusarium that could be recovered from the soil, as shown in FIG. 3.

[0016] The inventors conducted several other studies to determine whether the OBT 712 strain could reduce Fusarium counts in the absence of soy flour and whether the effect on Fusarium was due to soy flour alone or if the bacteria was required. One percent soy flour inoculated with 510.sup.8 cfu strain OBT 712 per gram of soybean flour would deliver 510.sup.6 cfu strain OBT 712 per gram of soil. Neither this concentration nor 510.sup.5 cfu strain OBT 712 per gram of soil appeared to appreciably affect Fusarium (FIG. 4). However, when compared to soy flour alone, soy flour plus strain OBT 712 reduced Fusarium recovery by approximately 80% (FIG. 5).

[0017] The inventors have concluded from the above experiments that a soil amendment comprising soy flour inoculated with Bacillus amyloliquefaciens can be used to reduce Fusarium infections in crops. Soy flour appears to have an advantage over other nitrogen sources tested. The amount of soy required to observe a beneficial effect on Fusarium recovery is much lower than other organic nitrogen supplies. At 0.5% soy flour, the nitrogen content of the potting soil is approximately 375 ppm. Typically one would want a nitrogen concentration in the 100-200 ppm range, but given that B. amyloliquefaciens is growing on the substrate and assimilating nitrogen it is conceivable that free nitrogen would be much lower than 200 ppm and that detrimental effects to the plant would not be observed.

[0018] Alternatively, fermentation broth in itself could make a suitable anti-fungal product. One could use routine experimentation to determine the percentage of the material that could be used as a fungicide. The secreted products that are likely responsible for the anti-fungal activity of the B. amyloliquefaciens strains are lipopeptides. Examples being iturin, surfactin, and fengycin. Genes encoding for enzymes required for the synthesis of these compounds are present in the strain OBT 712 genome. These peptides have been shown to be haemolytic and as a result have not been commercialized.

[0019] The compositions (inoculated protein sources and effluents from cultures) disclosed herein can be used to inhibit fungal infections in plants by applying the compositions to the plants, to seeds from which the plants are grown, or to soil in which the plants are grown. Soil concentrations generally refer to concentrations within soil that the roots of the plant contact. Application to seeds refers to incorporating the disclosed compositions in a seed covering. Effluents, refer to filtered liquids obtained from media in which the disclosed bacteria are cultured.

[0020] The described embodiments are preferred and/or illustrated, but are not limiting. Various modifications are considered within the purview and scope of the appended claims.